[S-04] Update on Diagnostic Biomarkers for the early diagnosis of Alzheimer's Disease

[S-04-2] Plasma Abeta as a biomarker for Alzheimer's disease

Koichi Tanaka (Koichi Tanaka Mass Spectrometry Research Laboratory Shimadzu Corporation, Japan)

In recent advance of Alzheimer research field, development of tau imaging　and novel plasma biomarkers provide new prospect of clinical research and drug development. In this symposium, four presentators will be presenting and discussing on diagnostic biomarkers and their impacts on the diagnosis of Alzheimer's disease.

Institution: Koichi Tanaka Mass Spectrometry Research Laboratory
Shimadzu Corporation
Position: Senior Fellow / General Manager,


Brief Resume of past and present actives
Degree
1983. 3 B.A., Engineering, Tohoku University

Experience
1983. 4　Central Research Laboratory, Shimadzu Corporation.
1986. 5 Scientific Measurement Instru. Div., R&D Dep., Shimadzu Corp.
1992. 1 KRATOS Group PLC. in UK
1992.12 Analytical Instrument Division, R&D Department, Shimadzu Corporation
1997. 4 Shimadzu Research Laboratory (Europe) Ltd. in UK
1999.12 KRATOS Group PLC in UK
2002. 5 Analytical & Measuring Instru. Div., Life Sci. Busi. Unit, Shimadzu Corporation
2002.11 Fellow, Shimadzu Corporation
2003. 1 General Manager, Mass Spectrometry Research Lab., Shimadzu Corporation
2012. 6　Senior Fellow Shimadzu Corporation

Honors & Awards
1989. 5 Encouragement Award from the Mass Spectroscopy Society of Japan
2002.11 Order of Cultural Merit Award
2002.12 Nobel Prize in Chemistry